Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · REGISTER · 2006-02-23 · P FEDERAL MARITIME COMMISSION · Notices

Notices. Notice

16,943 words·~77 min read·/register/2006/02/23/06-1690

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4810-33-P; 6210-01-P; 6714-01-P; 6720-01-P; 7535-01-P FEDERAL MARITIME COMMISSION Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments on an agreement to the Secretary, Federal Maritime Commission, Washington, DC 20573, within ten days of the date this notice appears in the **Federal Register** . Copies of agreements are available through the Commission's Office of Agreements (202-523-5793 or *tradeanalysis@fmc.gov* ). *Agreement No.:* 010050-017. *Title:* U.S.
Flag Discussion Agreement. *Parties:* American President Lines, Ltd.; APL Co. PTE Ltd.; A.P. Moller-Maersk A/S; CP Ships USA, LLC; and Farrell Lines, Inc. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment deletes P&O Nedlloyd Limited as a party to the agreement and changes Maersk's trade name. *Agreement No.:* 010051-036. *Title:* Mediterranean Space Charter Agreement. *Parties:* Farrell Lines, Inc.;
CP Ships USA LLC; A.P. Moller-Maersk A/S; Mediterranean Shipping Company, S.A.; P&O Nedlloyd Limited; P&O Nedlloyd B.V.; Hapag-Lloyd Container Linie GmbH; and Zim Integrated Shipping Services, Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment deletes the P&O Nedlloyd companies as parties to the agreement and changes Maersk's trade name. *Agreement No.:* 011268-020. *Title:* New Zealand/United States Discussion Agreement. *Parties:* New Zealand/United States Container Lines Association;
Hamburg-Su d; Australia-New Zealand Direct Line; FESCO Ocean Management Ltd.; A.P. Moller-Maersk A/S; and CP Ships USA, LLC. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW., Suite 900; Washington, DC 20036. *Synopsis:* The amendment deletes P&O Nedlloyd Limited as a party to the agreement and changes Maersk's trade name. *Agreement No.:* 011275-019. *Title:* Australia/United States Discussion Agreement. *Parties:* A.P. Moller-Maersk A/S; Australia-New Zealand Direct Line;
FESCO Ocean Management Inc.; Hamburg-Su d; NYKLauritzenCool AB; CP Ships USA, LLC; Safmarine Container Lines NV; and Seatrade Group N.V. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment changes Maersk's trade name and deletes P&O Nedlloyd Limited as a party to the agreement. *Agreement No.:* 011279-024. *Title:* Latin America Agreement. *Parties:* Central America Discussion Agreement; Hispaniola Discussion Agreement;
Caribbean Shipowners Association; Venezuelan Discussion Agreement; ABC Discussion Agreement; West Coast of South America Discussion Agreement; Inland Shipping Services Association; Montemar Maritima S.A.; and Zim Integrated Shipping Services, Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment updates the membership of various agreement parties. *Agreement No.:* 011290-036. *Title:* International Vessel Operators Hazardous Material Association Agreement. *Parties:* Alianc a Navegacao e Logistica Ltda.;
APL Co. PTE Ltd.; Atlantic Container Line AB; Australia-New Zealand Direct Line; Bermuda Container Line; Canada Maritime Agencies Ltd.; China Shipping Container Lines Co., Ltd.; CMA CGM, S.A.; Compania Latino Americana de Navegacion SA; Contship Containerlines; COSCO Container Lines, Inc.; CP Ships USA LLC; Crowley Maritime Corporation; Evergreen Marine Corp. (Taiwan) Ltd.; Hamburg-Su damerikanische Dampfschifffahrts-Gesellschaft KG; Hanjin Shipping Co., Ltd.; Hapag-Lloyd Container Linie GmbH;
Horizon Lines, LLC; Hyundai Merchant Marine Co., Ltd.; Independent Container Line Ltd.; Kawasaki Kisen Kaisha Ltd.; Marine Transport Lines, Inc.; Maruba SCA; Mitsui O.S.K. Lines, Ltd.; A.P. Moller-Maersk A/S; National Shipping Co. of Saudi Arabia; Nippon Yusen Kaisha Line; Orient Overseas Container Line Limited; P&O Nedlloyd B.V.; P&O Nedlloyd Limited; Safmarine Container Lines; Seaboard Marine Ltd.; Senator Lines GmbH; Tropical Shipping & Construction Co., Ltd.; United Arab Shipping Co.
S.A.G.; Yang Ming Marine Transport Corp.; and Zim Integrated Shipping Services, Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment adds Matson Navigation Company as a party to the agreement, deletes the P&O Nedlloyd companies as parties to the agreement, and changes Maersk's trade name. *Agreement No.:* 011346-016. *Title:* Israel Trade Conference Agreement. *Parties:* A.P. Moller-Maersk A/S;
Farrell Lines, Inc.; P&O Nedlloyd Limited; and Zim Integrated Shipping Services, Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment reflects P&O Nedlloyd's resignation effective April 11, 2006, and changes Maersk's trade name. *Agreement No.:* 011375-066. *Title:* Trans-Atlantic Conference Agreement. *Parties:* Atlantic Container Line AB; A.P. Moller-Maersk A/S; Mediterranean Shipping Company, S.A.;
Nippon Yusen Kaisha; and Orient Overseas Container Line Limited. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment deletes P&O Nedlloyd Limited as a party to the agreement effective February 17, 2006, and changes Maersk's trade name. *Agreement No.:* 011405-018. *Title:* Ocean Carrier Working Group Agreement. *Parties:* Latin America Agreement; Israel Trade Conference; Trans-Atlantic Conference Agreement;
Transpacific Stabilization Agreement; Middle East Indian Subcontinent Discussion Agreement; United States Australasia Discussion Agreement; United States/ South Europe Conference; Westbound Transpacific Stabilization Agreement; A.P. Moller-Maersk A/S; Contship Containerlines; Evergreen Marine Corporation (Taiwan) Ltd.; King Ocean Service de Venezuela, S.A.; Star Shipping A/S; Tropical Shipping & Construction Company, Limited; Wallenius Wilhelmsen Logistics AS; Zim Integrated Shipping Services, Ltd.; and Hapag-Lloyd Container Linie GmbH. *Filing Party:* Wayne R.
Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment updates the membership of various agreement parties and the names of various carrier parties. *Agreement No.:* 011547-020. *Title:* Eastern Mediterranean Discussion Agreement. *Parties:* Farrell Lines, Inc.; COSCO Container Lines Co. Ltd.; China Shipping Container Lines Co., Ltd.; A.P. Moller-Maersk A/S; Mediterranean Shipping Company, S.A.; Turkon Container Transportation & Shipping, Inc.; and Zim Integrated Shipping Services, Ltd. *Filing Party:* Wayne R.
Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment removes P&O Nedlloyd Limited as a party effective March 12, 2006. *Agreement No.:* 011654-014. *Title:* Middle East Indian Subcontinent Discussion Agreement. *Parties:* American President Lines; A.P. Moller-Maersk A/S; China Shipping Navigation Co., Ltd. d/b/a Indotrans; CMA CGM S.A.; Contship Containerlines, a division of CP Ships
(UK)Ltd.; MacAndrews & Company Limited; P&O Nedlloyd Limited; The National Shipping Company of Saudi Arabia; and United Arab Shipping Company (S.A.G.). *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment deletes American President Lines and P&O Nedlloyd Limited as parties to the agreement and changes Maersk's trade name. *Agreement No.:* 011904-001. *Title:* Atlantic Brazil Express Agreement. *Parties:* CMA CGM, S.A.; P&O Nedlloyd Limited; and P&O Nedlloyd B.V. *Filing Party:* Neal M. Mayer, Esq.; Hoppel, Mayer & Coleman; 1050 Connecticut Avenue, NW.; 10th Floor; Washington, DC 20036. *Synopsis:* The amendment deletes the P&O Nedlloyd companies as parties to the agreement and adds A.P. Moller-Maersk A/S, trading as Maersk Line, as a party. *Agreement No.:* 011907-002. *Title:* ABX/APL Space Charter Agreement. *Parties:* CMA CGM S.A.; APL Co. Pte Ltd.; P&O Nedlloyd Limited; and P&O Nedlloyd B.V. *Filing Party:* Neal M. Mayer, Esq.; Hoppel, Mayer & Coleman; 1050 Connecticut Avenue, NW.; 10th Floor; Washington, DC 20036. *Synopsis:* The amendment deletes the P&O Nedlloyd companies as parties to the agreement and adds A.P. Moller-Maersk A/S, trading as Maersk Line, as a party. *Agreement No.:* 011917-001. *Title:* Maersk Line/MOL Space Charter Agreement. *Parties:* A.P. Moller Maersk A.S. and Mitsui O.S.K. Lines, Ltd. *Filing Party:* Neal M. Mayer, Esq.; Hoppel, Mayer & Coleman; 1050 Connecticut Avenue, NW.; Washington, DC 20036. *Synopsis:* The amendment removes P&O Nedlloyd B.V. and P&O Nedlloyd Limited as parties, adds A.P. Moller Maersk A/S as a party, and renames the agreement as the Maersk Line/MOL Space Charter Agreement. *Agreement No.:* 011941. *Title:* CMA CGM/LT/GSL Amerigo Express 2 MUS Cross Space Charter, Sailing and Cooperative Working Agreement. *Parties:* CMA CGM, S.A.; Lloyd Triestino di Navigazione S.p.A.; and Gold Star Line Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The agreement authorizes the parties to share vessel space in the trade between the U.S. Atlantic Coast and Italy, France, Spain, Portugal, Malta, and Turkey. *Agreement No.:* 011942. *Title:* CMA-CGM/CSCL Cross Space Charter, Sailing and Cooperative Working Agreement—Far East/US Gulf Loop, PEX2/AAE2 Service. *Parties:* CMA-CGM, S.A.; China Shipping Container Lines Co., Ltd.; and China Shipping Container Lines (Hong Kong) Co., Ltd. *Filing Party:* Brett M. Esber, Esq.; Blank Rome LLP; Watergate; 600 New Hampshire Ave., NW.; Washington, DC 20037. *Synopsis:* The agreement authorizes the parties to share vessel space in a weekly liner service between ports on the U.S. Atlantic and Gulf Coasts and ports in Asia (China, Hong Kong, Taiwan, and Korea), the Caribbean (Jamaica, Mexico), and Central America (Panama) and engage in related cooperative activities. *Agreement No.:* 011943. *Title:* CMA-CGM/CSCL Cross Space Charter, Sailing and Cooperative Working Agreement—Far East/Pacific North West Loop, ANW/Seattle Bridge Service. *Parties:* CMA-CGM, S.A.; and China Shipping Container Lines Co., Ltd.; and China Shipping Container Lines (Hong Kong) Co., Ltd. *Filing Party:* Brett M. Esber, Esq.; Blank Rome LLP; Watergate; 600 New Hampshire Ave., NW.; Washington, DC 20037. *Synopsis:* The agreement authorizes the parties to share vessel space in a weekly liner service between ports on the U.S. Pacific Coast and ports in Asia (China, Hong Kong, Taiwan, and Korea) and engage in related cooperative activities. Dated: February 17, 2006. By order of the Federal Maritime Commission. Bryant L. VanBrakle, Secretary. [FR Doc. E6-2594 Filed 2-22-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Revocations The Federal Maritime Commission hereby gives notice that the following Ocean Transportation Intermediary licenses have been revoked pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. app. 1718) and the regulations of the Commission pertaining to the licensing of Ocean Transportation Intermediaries, effective on the corresponding date shown below: *License Number:* 015702N. *Name:* Anndex Consolidators, Inc. *Address:* 255 NE 59th Street, Miami, FL 33137. *Date Revoked:* January 12, 2006. *Reason:* Surrendered license voluntarily. *License Number:* 003386F. *Name:* Del-Mar International, Inc. *Address:* 10333 Northwest Freeway, #214, Houston, TX 77092. *Date Revoked:* January 27, 2006. *Reason:* Surrendered license voluntarily. *License Number:* 015795N. *Name:* Eurocargo Express, LLC dba Eurocargo Express. *Address:* 5250 West Century Blvd., Suite 620, Los Angeles, CA 90045. *Date Revoked:* January 7, 2006. *Reason:* Failed to maintain a valid bond. *License Number:* 016328N. *Name:* Northeast Consolidators, Inc. *Address:* 58 Batterymarch Street, Boston, MA 02110. *Date Revoked:* December 27, 2005. *Reason:* Surrendered license voluntarily. *License Number:* 000791F. *Name:* Sig M. Glukstad dba Miami International Forwarders dba MIF. *Address:* 1801 NW 82nd Avenue, Miami, FL 33126. *Date Revoked:* January 5, 2006. *Reason:* Failed to maintain a valid bond. *License Number:* 003334NF. *Name:* Vantage International Forwarding Ltd. *Address:* 11222 La Cienega Blvd., Suite 535, Inglewood, CA 90304. *Date Revoked:* January 31, 2006. *Reason:* Surrendered license voluntarily. *License Number:* 003476F. *Name:* Victory Van Lines, Inc. *Address:* 357 Targee Street, Staten Island, NY 10304. *Date Revoked:* December 31, 2005. *Reason:* Failed to maintain a valid bond. Sandra L. Kusumoto, Director, Bureau of Certification and Licensing. [FR Doc. E6-2587 Filed 2-22-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Applicants Notice is hereby given that the following applicants have filed with the Federal Maritime Commission an application for license as a Non-Vessel—Operating Common Carrier and Ocean Freight Forwarder—Ocean Transportation Intermediary pursuant to section 19 of the Shipping Act of 1984 as amended (46 U.S.C. app. 1718 and 46 CFR 515). Persons knowing of any reason why the following applicants should not receive a license are requested to contact the Office of Transportation Intermediaries, Federal Maritime Commission, Washington, DC 20573. Non-Vessel—Operating Common Carrier Ocean Transportation Intermediary Applicants Harborside Logistics, 94 Commercial Street, Suite 201, Portland, ME 04101-4738. Officer: Christopher Robinson, President. (Qualifying Individual) Baycor International, LLC, 3154 McKaughan Road, Bay #6, Houston, TX 77032. Officers: Jorge A. Aponte, President. (Qualifying Individual) Leonel Barreto, Manager. Fastland Shipping, Inc., 1990 Westweed Blvd., Suite #240, Los Angeles, CA 90025. Officers: Adel Y. Abdelmooti, President. (Qualifying Individual) Sami A. Mekhemar, Vice President. Fremart International Inc., 17700 Castleton Street, Suite 338, City of Industry, CA 91748. Officer: Jin Zhao, President. (Qualifying Individual) Non-Vessel—Operating Common Carrier and Ocean Freight Forwarder Transportation Intermediary Applicant MTGLOBAL, INC., 16901 Keegan Avenue, Carson, CA 90746. Officer: Cynthia K. Narksuriya, CEO. (Qualifying Individual) Kerem Yogurtcugil, Vice President. Ocean Freight Forwarder—Ocean Transportation Intermediary Applicants Scanwell Logistics (CHI), 2455 Arthur Avenue, Elk Grove Village, IL 60007. Officers: Dennis Choy, President. (Qualifying Individual) Adam Hassam, Chairman. Legero International Houston, Inc., 2502 Farrell Road, Houston, TX 77073. Officer: Elwin Cornelisse, Managing Director. (Qualifying Individual) Scanwell Logistics
(CMH)Inc., 7200 Alum Creek Drive, Suite I, Columbus, OH 43217. Officers: Dennis Choy, President. (Qualifying Individual) Adam Hassam, Chairman. BPD International Inc., 13152 Rivergate Trail West, Jacksonville, FL 32223. Officer: Bahtiyar Yurdakul, President. (Qualifying Individual) Dated: February 17, 2006. Bryant L. VanBrakle, Secretary. [FR Doc. E6-2585 Filed 2-22-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than March 9, 2006. **A. Federal Reserve Bank of Kansas City** (Donna J. Ward, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198-0001: *1. Trenton W. Brown* , Ponca City, Oklahoma; Lisa D. Kessler, Scottsdale, Arizona; Mark R. Brown, Scottsdale, Arizona; Mary J. Brown, Arkansas City, Kansas; R. A. Brown, Arkansas City, Kansas; Roger A. Brown, Arkansas City, Kansas; Suzanne W. Brown, Arkansas City, Kansas; Charlotte B. Delaney, Winnetka, Illinois; and Rebecca R. Warren, Ponca City, Oklahoma, to acquire voting shares of HNB Corporation, Arkansas City, Kansas, and thereby indirectly acquire voting shares of Home National Bank, Blackwell, Oklahoma. Board of Governors of the Federal Reserve System, February 17, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6-2538 Filed 2-22-06; 8:45 am] BILLING CODE 6210-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Request for Nominations of Members to the Advisory Committee on Blood Safety and Availability AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. Authority: 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended. The Advisory Committee on Blood Safety and Availability is governed by the provision of Public Law 92-463, as amended (5 U.S.C. Appendix 2) which sets forth standards for the formation and use of advisory committees. SUMMARY: The Office of Public Health and Science
(OPHS)is seeking nomination of qualified individuals to be considered for appointment as members on the Advisory Committee on Blood Safety and Availability (ACBSA). ACBSA is a Federal advisory committee in the Department of Health and Human Services. Management support for the activities of the Committee are the responsibility of OPHS. The qualified individuals will be nominated to the Secretary of Health and Human services for consideration of appointment as members of the ACBSA. Members of the Committee, including the Chair, are appointed by the Secretary. Members are invited to serve on the Committee for overlapping three-year terms. DATES: All nominations must be received no later than 4 p.m. e.d.t. April 3, 2006, at the address listed below. ADDRESSES: All nominations shall be mailed or delivered to Jerry Holmberg, PhD, Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Science, Department of Health and Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD 20852. Phone
(240)453-8803. FOR FURTHER INFORMATION CONTACT: Jerry Holmberg, PhD, Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Science, Department of Health and Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD 20852. Phone
(240)453-8803. A copy of the Committee charter and roster of the current membership can be obtained by contacting Dr. Holmberg or by accessing the ACBSA Web site at *http//www.hhs.gov/bloodsafety.* SUPPLEMENTARY INFORMATION: The ACBSA provides advice and assistance, consults with, and makes recommendations to the Secretary and the Assistant Secretary for Health on a broad range of policy issues regarding the collection, preparation, and distribution of blood and blood products. The broad range of issues the Committee provides policy advice on includes
(1)Definition of public health parameters around safety and availability of the blood supply,
(2)broad public health, ethical, and legal issues related to blood safety, and
(3)the implications for blood safety and availability of various economic factors affecting product cost and supply. The ACBSA consists of 18 voting members. The Committee is composed of 12 public members, including the Chair, and six
(6)representative members. The public members are selected from State and local organizations, advocacy groups, provider organizations, academic researchers, ethicists, private physicians, scientists, consumer advocates, legal organizations, and from among communities of persons who are frequent recipients of blood or blood products. The six individuals who are appointed as official representative members are selected to serve the interests of the blood and blood products industry or professional organizations. The representative members are selected from the following groups: The American Association of Blood Banks, one of two major distributors of blood on a rotating basis, a trade organization or manufacturer of blood test kits or equipment, a company that produces leukoreduction processes, a major hospital organization that purchases blood and blood products, and a plasma protein therapeutic association. All ACBSA members are authorized to receive the prescribed per diem allowance and reimbursement for travel expenses that are incurred to attend meetings and conduct Committee-related business, in accordance with Standard Government Travel Regulations. Individuals who are appointed to serve as public members are authorized also to receive a stipend for attending Committee meetings and to carry out other Committee-related business. Individuals who are appointed to serve as representative members for a particular interest group or industry are not authorized to receive a stipend for the performance of these duties. This announcement is to solicit nominations of qualified candidates to fill positions on the ACBSA that are scheduled to be vacated in the public member category. The positions are scheduled to be vacated on September 30, 2006. Nominations In accordance with the charter, persons nominated for appointment as members of the ACBSA should be among authorities knowledgeable in blood banking, transfusion medicine, plasma therapies, bioethics and/or related disciplines. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration of appointment:
(a)The name, return address, daytime telephone number and affiliation(s) of the individual being nominated, the basis for the individual's nomination, the category for which the individual is being nominated, and a statement bearing an original signature of the nominated individual that, if appointed, he or she is willing to serve as a member of the Committee;
(b)the name, return address, and daytime telephone number at which the nominator may be contacted. Organizational nominations must identify a principal contact person in addition to the contact; and
(c)a copy of a current curriculum vitae or resume for the nominated individual. Individuals can nominate themselves for consideration of appointment to the Committee. All nominations must include the required information. Incomplete nominations will not be processed for consideration. The letter from the nominator and certification of the nominated individual must bear original signatures; reproduced copies of these signatures are not acceptable. The Department of Health and Human Services is committed to ensuring that women, minority groups, and physically challenged individuals are adequately represented on the Committee. Nominations of qualified candidates from these categories are encouraged. The Department also seeks to have geographic diversity reflected in the composition of the Committee. The Standards of Ethical Conduct for Employees of the Executive Branch are applicable to individuals who are appointed as public members of Federal advisory committees. Individuals appointed to serve as public members of Federal advisory committees are classified as special Government employees (SGEs). SGEs are Government employees for purposes of the conflict of interest laws. Therefore, individuals appointed to serve as public members of the ACBSA are subject to an ethics review. The ethics review is conducted to determine if the individual has any interest and/or activities in the private sector that may conflict with performance of their official duties as a member of the Committee. Individuals appointed to serve as public members of the Committee will be required to disclose information regarding financial holdings, consultancies, and research grants and/or contracts. Dated: February 14, 2006. Jerry A. Holmberg, Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. E6-2561 Filed 2-22-06; 8:45 am] BILLING CODE 4150-41-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Secretary's Advisory Committee on Human Research Protections AGENCY: Department of Health and Human Services, Office of the Secretary. ACTION: Notice. SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee Act, (U.S.C. Appendix 2), notice is hereby given that the Secretary's Advisory Committee on Human Research Protections (SACHRP), will hold its tenth meeting. The meeting will be open to the public. DATES: The meeting will be held on Monday, March 13, 2006 from 8:30 a.m. until 5 p.m. and Tuesday, March 14, 2006 from 8:30 a.m. until 4:30 p.m. ADDRESSES: The Radisson Hotel Old Town Alexandria, 901 North Fairfax Street, Alexandria, VA 22314. FOR FURTHER INFORMATION CONTACT: Bernard Schwetz, D.V.M., PhD, Director, Office for Human Research Protections, or Catherine Slatinshek, Executive Director, Secretary's Advisory Committee on Human Research Protections; Department of Health and Human Services, 1101 Wootton Parkway, Suite 200, Rockville, MD 20852;
(240)453-6900; fax:
(240)453-6909; e-mail address: *sachrp@osophs.dhhs.gov* . SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, SACHRP was established to provide expert advice and recommendations to the Secretary of Health and Human Services and the Assistant Secretary for Health on issues and topics pertaining to or associated with the protection of human research subjects. On March 13, 2006, SACHRP will receive and discuss preliminary reports from its Subpart A Subcommittee, which is evaluating the provisions of the HHS regulations for the protection of human subjects at Subpart A of 45 CFR part 46 and related OHRP guidance. On March 14, 2006, the Subcommittee on Research Involving Children will present another in a series of reports to the members of the Committee. The subcommittees were established by SACHRP at its October 4-5, 2004 meeting and at its inaugural meeting on July 22, 2003, respectively. On March 14, 2006, the Committee will host presentations and invite discussions from panelists concerning issues on research ethics training at international sites. Topics discussed will include developing and carrying out educational programs in research ethics in developing countries; federal interactions with industry in studies overseas; how the FDA monitors compliance with regulations and ethical guidelines, and other issues. Public attendance at the meeting is limited to space available. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact persons. Members of the public will have the opportunity to provide comments on both days of the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed materials distributed to SACHRP members for this scheduled meeting should submit materials to the Executive Director, SACHRP, prior to the close of business Wednesday, March 8, 2006. Information about SACHRP and the draft meeting agenda will be posted on the SACHRP Web site at: *http://ohrp.osophs.dhhs.gov/sachrp/sachrp.htm* . Dated: February 16, 2006. Bernard A. Schwetz, Director, Office for Human Research Protections, Executive Secretary, Secretary's Advisory Committee on Human Research Protections. [FR Doc. E6-2560 Filed 2-22-06; 8:45 am] BILLING CODE 4150-36-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [ATSDR-218] Availability of Final Toxicological Profiles AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Notice of availability. SUMMARY: This notice announces the availability of one new and seven updated final toxicological profiles of priority hazardous substances comprising the seventeenth set prepared by ATSDR. FOR FURTHER INFORMATION CONTACT: Ms. Olga Dawkins, Division of Toxicology and Environmental Medicine, Agency for Toxic Substances and Disease Registry, Mailstop F-32, 1600 Clifton Road, NE., Atlanta, Georgia 30333, telephone
(770)488-3315. Electronic access to these documents is also available at the ATSDR website: *http://www.atsdr.cdc.gov/toxpro2.html.* SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization Act of 1986
(SARA)(42 U.S.C. 9601 *et seq.* ) amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) (42 U.S.C. 9601 *et seq.* ) by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA)with regard to hazardous substances that are most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the priority lists of hazardous substances. These lists identified 275 hazardous substances that ATSDR and EPA determined pose the most significant potential threat to human health. The availability of the revised list of the 275 priority substances was announced in the **Federal Register** on December 7, 2005 (70 FR 234). For prior versions of the list of substances, see **Federal Register** notices dated April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); February 28, 1994 (59 FR 9486); April 29, 1996 (61 FR 18744); November 17, 1997 (62 FR 61332); October 21, 1999 (64 FR 56792); October 25, 2001 (66 FR 54014) and November 7, 2003 (68 FR 63098). Notice of the availability of drafts of these seven updated and one new toxicological profiles for public review and comment was published in the **Federal Register** on October 23, 2003, (68 FR 60696), with notice of a 90-day public comment period for each profile, starting from the actual release date. Following the close of the comment period, chemical-specific comments were addressed, and, where appropriate, changes were incorporated into each profile. The public comments and other data submitted in response to the **Federal Register** notices bear the docket control number ATSDR-197. This material is available for public inspection at the Division of Toxicology, Agency for Toxic Substances and Disease Registry, 1825 Century Boulevard, Atlanta, Georgia, (not a mailing address) between 8:00 a.m. and 4:30 p.m., Monday through Friday, except legal holidays. Availability This notice announces the availability of one new and seven updated final toxicological profiles of priority hazardous substances comprising the seventeenth set prepared by ATSDR. The following toxicological profiles are now available through the U.S. Department of Commerce, National Technical Information Service (NTIS), 5285 Port Royal Road, Springfield, Virginia 22161, telephone 1-800-553-6847. There is a charge for these profiles as determined by NTIS. Seventeenth Set: Toxicological profile NTIS order No. CAS No. 1. Bromoform/ PB2006-100001 000075-25-2 Dibromochloromethane 000124-48-1 2. Carbon Tetrachloride PB2006-100002 000056-23-5 3. Hexachlorocyclohexane (gamma) PB2006-100003 000058-89-9 Hexachlorocyclohexane
(beta)000319-85-7 Hexachlorocyclohexane (delta) 000319-86-8 Hexachlorocyclohexane (alpha) 000319-84-6 Hexachlorocyclohexane (technical) 000608-73-1 4. Naphthalene PB2006-100004 000091-20-3 1-Methyl Naphthalene 000090-12-0 2-Methyl Naphthalene 000091-57-6 5. Nickel PB2006-100005 007440-02-0 6. Tin PB2006-100006 007440-31-5 7. Tungsten * PB2006-100007 007440-33-7 8. Zinc PB2006-100008 007440-66-6 Note.—* Denotes new profile. Kevin A. Ryan, Acting Director, Office of Policy, Planning and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. [FR Doc. E6-2577 Filed 2-22-06; 8:45 am] BILLING CODE 4163-70-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration on Aging Agency Information Collection Activities; Extension of Existing Collection; Comment Request; Title VI Program Performance Report AGENCY: Administration on Aging, HHS. ACTION: Notice. SUMMARY: The Administration on Aging
(AoA)is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the **Federal Register** concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection requirements relating to the Title VI Program Performance Report. DATES: Submit written or electronic comments on the collection of information by April 24, 2006. ADDRESSES: Submit electronic comments on the collection of information to: *Yvonne.Jackson@aoa.gov* . Submit written comments on the collection of information to: Dr. Yvonne Jackson, Administration on Aging, Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Dr. Yvonne Jackson, Director; Office of American Indian, Alaskan Native and Native Hawaiian Programs, U.S. Department of Health and Human Services, Administration on Aging, Washington, DC 20201;
(202)357-3501. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget
(OMB)for each collection of information they conduct or sponsor. “Collection of information” is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency request or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the **Federal Register** concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, AoA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, AoA invites comments on:
(1)Whether the proposed collection of information is necessary for the proper performance of AoA's functions, including whether the information will have practical utility;
(2)the accuracy of AoA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
(3)ways to enhance the quality, utility, and clarity of the information to be collected; and
(4)ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques when appropriate, and other forms of information technology. The Program performance Report provides a data base for AoA to
(1)monitor program achievement of performance objectives;
(2)establish program policy and direction, and
(3)prepare responses to Congress, the Office of Management and Budget, the General Accounting Office, other Federal departments, and public and private agencies as required by the OAA Title II sections 202(a)19 and 208; and prepare data for the Federal Interagency Task Force of Older Indians established pursuant to section 134(d) of the 1987 Amendments to the OAA. AoA estimates the burden of this collection of information as follows: A total of not more than 729 hours per year will be required to prepare reports. Dated: February 17, 2006. Francis A. Burns, Deputy Assistant Secretary for Wellness and Community Based Services. [FR Doc. E6-2537 Filed 2-22-06; 8:45 am] BILLING CODE 4154-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-06-06AR] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention
(CDC)publishes a list of information collection requests under review by the Office of Management and Budget
(OMB)in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at
(404)639-5960 or send an e- mail to *omb@cdc.gov.* Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to
(202)395-6974. Written comments should be received within 30 days of this notice. Proposed Project Home Medkit Evaluation Study (HoME Study)—New—Coordinating Office for Terrorism Preparedness and Emergency Response (COTPER), Centers for Disease Control and Prevention (CDC). The Coordinating Office for Terrorism Preparedness and Emergency Response (COTPER), Centers for Disease Control and Prevention
(CDC)proposes to conduct a one-time-only study called the Home Medkit Evaluation Study (HoME Study). This pilot study will be conducted with selected St. Louis, Missouri area households who volunteer. Volunteers would receive in their homes FDA-approved medicines that are to be reserved for emergency use in the event of specific public health emergency conditions resulting from a bioterrorist threat. The proposed study will provide data on the extent to which people with diverse backgrounds are able to follow instructions concerning appropriate storage and to reserve the medicine for emergency use only. Approximately, 5,000 volunteer households will be recruited in the St. Louis, Missouri metropolitan area, and divided among three cohorts:
(a)Public health emergency responders and their household members,
(b)employees of a large corporate operation and their household members, and
(c)clients of publicly-funded primary healthcare centers, their households, and surrounding community households. All will be medically screened for eligibility to receive a home MedKit and, if eligible, they will be recruited and enrolled for study participation with informed consent. After an initial in-person baseline interview, they will receive a MedKit bag with an antibiotic enclosed. The MedKit bag will consist of a transparent mylar, tamper-evident sealed bag with FDA-approved patient instructions affixed to the outside and individual MedKits—cardboard notebook blister packs with doses for each household member and patient instructions, including FDA-approved crushing instructions for administration of emergency pediatric doses. The information collected from this study will be used to:
(1)Assess the ability of volunteers from select populations to store and maintain household MedKits as directed and to refrain from inappropriate use;
(2)explore attitudes, perceptions, and other social and psychological factors that influence participant behavior in relation to the MedKit; and
(3)inform policy makers and national planners about the acceptability, safety, durability, and usefulness of the household MedKit strategy and supporting documentation. There are no previous or existing studies to provide the specific information to answer the research questions proposed in the HoME Study. There are no costs to the respondents other than their time. The total annualized burden hours are 7,253. Estimated Annualized Burden Hours Form type/respondent category Number of Respondents Frequency of response Hours per response BEHAVIORAL STUDY: Recruiting HH Contacts 20,000 1 2/60 Prescreening & HH Roster 4,914 1 5/60 Medical Screening: PH 1st responder HHs 3,800 1 15/60 Large business partner HHs 3,800 1 15/60 CHC client HHs 3,800 1 15/60 Baseline Questionnaire: PH 1st responder HHs 1,227 1 20/60 Large business partner HHs 1,282 1 20/60 PHC client HHs 1,430 1 20/60 Follow-Up Questionnaire: PH 1st responder HHs 1,227 1 25/60 Large business partner HHs 1,282 1 25/60 PHC client HHs 1,430 1 25/60 NESTED QUALITATIVE STUDIES: Screening & Recruitment calls: Study HHs focus groups 180 1 5/60 Non-English speakers focus groups 40 15/60 In-depth Interview 80 1 5/60 Focus Groups: PH 1st responders 40 1 2 Large business partner employees 40 1 2 PHC client 40 1 2 Non-English speakers 20 1 2 In-depth Interviews 60 1 1 Notes for Table A.12.1: HH=Household; PHC=Public Health Clinic. Dated: February 15, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6-2583 Filed 2-22-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-06-04JZ] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention
(CDC)publishes a list of information collection requests under review by the Office of Management and Budget
(OMB)in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at
(404)639-4794 or send an email to *omb@cdc.gov.* Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to
(202)395-6974. Written comments should be received within 30 days of this notice. Proposed Project Preventive Cardiac Health Care Knowledge, Beliefs, and Behaviors in Female Carriers of Duchenne/Becker Muscular Dystrophy—New—National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC). Background and Brief Description Duchenne/Becker Muscular Dystrophy
(DBMD)is the most common form of fatal muscular dystrophy in children. It affects about 1 in 3,500 boys. Although almost all cases of DBMD are diagnosed in young males, the genetic condition that causes DBMD is carried by females. Today, there are about 40,000 female DBMD carriers in the United States. Females who carry this genetic condition generally do not have symptoms, but some may experience muscle weakness and fatigue. Sometimes, they may also develop heart problems that are characterized by shortness of breath or an inability to do moderate exercise. The chance that a female carrier will develop heart problems is unknown, but these heart problems are serious and can be life threatening. To learn more about the heart health behaviors of adult female DBMD carriers, National Center on Birth Defects and Developmental Disabilities (NCBDDD), CDC proposes to conduct a national survey. This one-time survey will be mailed to about 7,000 women who are on mailing lists maintained by DBMD advocacy groups (Group 1) or are known by someone on one of the lists (Group 2). The data will be treated in a confidential manner. Women will be eligible to complete the survey if they are at least 19 years old and have given birth to a son with DBMD or been told that they definitely or probably carry a genetic change for DBMD. To comply with requests from the advocacy community, the questionnaire will be provided to friends, relatives, and acquaintances of women on the above mailing lists who meet all study eligibility criteria and personally initiate contact with the study office about possible participation (Group 2). All study materials, including the questionnaire, will be available in English and Spanish. Respondents will also be able to complete an electronic version of the survey accessed via the World Wide Web. It will take each participant about 5 minutes to read the survey cover letter and about 30 minutes to complete the survey. Group 2 women will also need to complete a 5-minute telephone interview to provide their mailing address to the study office. Prior to receiving the survey, Group 1 women will receive an initial approach letter that will take about 5 minutes to read. We expect that 80% of the women who receive a questionnaire will complete the survey, for a total of 5,600 respondents. Survey participants will be asked about social and psychological aspects of their genetic carrier status, their sources of social support, their awareness and knowledge of the link between carrier status and heart health, issues about access to specialized cardiac health care, and sources of health information that they find trustworthy, accessible, and understandable. Postage and a return envelope will be provided for participants who choose to complete and return their survey by mail. There are no costs to the respondents other than their time. The total estimated annualized burden hours are 3,968. Estimated Annualized Burden Table Type of data collection Number of respondents Number of responses per respondent Average burden per respondent (in hours) Initial approach letter (Primary sample only) 6,000 1 5/60 Telephone screen (Secondary sample only) 1,000 1 5/60 Survey cover letter with survey (Primary & Secondary samples) 7,000 1 5/60 Survey sections 1 through 5 5,600 1 30/60 Dated: February 15, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6-2584 Filed 2-22-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Administration on Developmental Disabilities; Help America Vote Act
(HAVA)Training and Technical Assistance (T/TA) To Assist Protection and Advocacy Systems (P&As) To Establish or Improve Voting Access for Individuals With Disabilities *Announcement Type:* Initial—Grant. *Funding Opportunity Number:* HHS-2006-ACF-ADD-DH-0034. *CFDA Number:* 93.618. *Due Date for Letter of Intent:* March 27, 2006. *Due Date for Applications:* April 24, 2006. *Executive Summary:* The Administration on Developmental Disabilities
(ADD)in the Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), announces the availability of Fiscal Year
(FY)2006 funds for the Help America Vote Act
(HAVA)Training and Technical Assistance (T/TA) for Protection and Advocacy Systems (P&As). The purpose of funds awarded under this announcement is to provide T/TA to P&As in their promotion of full participation in the electoral process for individuals with disabilities, including registering to vote, casting a vote, and accessing polling places; developing proficiency in the use of voting systems and technologies as they affect individuals with disabilities (including blindness) in order to assess the availability and use of such systems and technologies for such individuals. At least one recipient of these funds must provide T/TA for non-visual access. I. Funding Opportunity Description Legislative Authority The Help America Vote Act
(HAVA)of 2002, Public Law (Pub. L.) 107-252, Title II, Subtitle D, part 5, section 291. Description The Administration on Developmental Disabilities
(ADD)in the Administration for Children and Families (ACF), the U.S. Department of Health and Human Services (HHS), announces the availability of Fiscal Year
(FY)2006 funds authorized under the Help America Vote Act
(HAVA)of 2002, Public Law 107-252, Title II, Subtitle D, part 5, section 291 (42 U.S.C. 15461). Provisions under this section provide for the award of grants for Training and Technical Assistance (T/TA) to assist Protection and Advocacy Systems (P&As) in: * Promoting full participation in the electoral process for individuals with disabilities, including registering to vote, casting a vote, and accessing polling places; * Developing proficiency in the use of voting systems and technologies as they affect individuals with disabilities; * Demonstrating and evaluating the use of such systems and technologies by individuals with disabilities (including blindness) in order to assess the availability and use of such systems and technologies for such individuals; and * Providing T/TA for non-visual access. (At least one recipient must provide T/TA assistance in this area.) Background HAVA, signed into law by President George W. Bush on October 29, 2002, contains three grant programs that will enable a grantee to establish, expand, and improve access to and participation in the election process by individuals with the full range of disabilities ( *e.g.* , visual impairments including blindness, hearing impairments including deafness, the full range of mobility impairments including gross motor and fine motor impairments, emotional impairments, and intellectual impairments). These programs are:
(1)Voting Access for Individuals with Disabilities (VOTE), which provides funding to the States and territories for activities to establish and/or improve access to voting for individuals with the full range of disabilities;
(2)Protection and Advocacy Systems: Help America to Vote, which provides funding to P&As throughout the United States in support of their efforts to ensure full participation in the electoral process for individuals with disabilities; and
(3)T/TA for P&As so they can assist individuals with the full range of disabilities in the voting process from registration to actual voting. Background on ADD and ADD Programs ADD is located within ACF, HHS. ADD shares goals with other ACF programs that promote the economic and social well-being of families, children, individuals, and communities. ADD is the lead agency responsible for planning and administering programs to promote the self-sufficiency and protect the rights of persons with developmental disabilities. ADD administers the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (the DD Act). The DD Act provides for funding to States to provide advocacy, promote consumer oriented systems change and capacity building activities, and facilitate network collaboration. The four programs funded under the DD Act are:
(1)State Councils on Developmental Disabilities that engage in advocacy, capacity building, and systemic change activities;
(2)Protection and Advocacy Systems (P&As) that protect the legal and human rights of individuals with developmental disabilities;
(3)The National Network of University Centers for Excellence in Developmental Disabilities, (UCEDD) that engages in training, community outreach, research, and dissemination activities; and
(4)Projects of National Significance (PNS), that award grants and contracts that promote and increase the independence, productivity, inclusion and integration into the community of persons with developmental disabilities. These projects focus on the most pressing issues for people with developmental disabilities across the country. These projects may involve research, technical assistance, projects which improve supportive living and quality of life opportunities, projects to educate policymakers, and efforts to create interagency Federal collaboration. In addition to responsibilities under the DD Act, ADD has been given the responsibility by the Secretary of HHS for three grant programs authorized under HAVA, Public Law 107-252. This announcement is for HAVA T/TA for P&As so they can assist individuals with disabilities in the voting process from registration to actual voting. Objectives The purpose of funds awarded under this announcement is to provide T/TA for P&As to establish or improve voting access for individuals with disabilities, including registering to vote, casting a vote and accessing polling places. The T/TA grantee(s) may use their award to support training in the use of voting systems and technologies, and to demonstrate and evaluate the use of such systems and technologies, by individuals with disabilities (including blindness) in order to assess the availability and use of such systems and technologies for such individuals. At least one grantee shall use the award to provide T/TA for nonvisual access. II. Award Information *Funding Instrument Type:* Grant. *Anticipated Total Priority Area Funding:* $338,115. *Anticipated Number of Awards:* 1 to 4. *Ceiling on Amount of Individual Awards:* $338,115 per budget period. *Floor on Amount of Individual Awards:* $84,529 per budget period. *Average Projected Award Amount:* $84,529 per budget period. *Length of Project Periods:* 12-month project and budget period. Awards under this announcement are subject to the availability of funds. III. Eligibility Information 1. *Eligible Applicants:* * Public and State-controlled institutions of higher education. * Non-profits having a 501(c)(3) status with the IRS, other than institutions of higher education. * Non-profits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education. * Private institutions of higher education. Faith-based and community organizations that meet the statutory eligibility requirements are eligible to apply under this announcement. As stated in the HAVA of 2002, Public Law 107-252, Title II, Subtitle D, part 5, section 291(c)(3), in order for an entity to establish eligibility, the entity must show that it:
(A)Is a public or private non-profit entity with demonstrated experience in voting issues for individuals with disabilities;
(B)is governed by a board with respect to which the majority of its members are individuals with disabilities or family members of such individuals or individuals who are blind; and
(C)submits to the HHS Secretary an application as required under this announcement. 2. *Cost Sharing or Matching:* None. 3. *Other:* D-U-N-S Requirement All applicants must have a D&B Data Universal Numbering System (D-U-N-S) number. On June 27, 2003, the Office of Management and Budget
(OMB)published in the **Federal Register** a new Federal policy applicable to all Federal grant applicants. The policy requires Federal grant applicants to provide a D-U-N-S number when applying for Federal grants or cooperative agreements on or after October 1, 2003. The D-U-N-S number will be required whether an applicant is submitting a paper application or using the government-wide electronic portal, Grants.gov. A D-U-N-S number will be required for every application for a new award or renewal/continuation of an award, including applications or plans under formula, entitlement, and block grant programs, submitted on or after October 1, 2003. Please ensure that your organization has a D-U-N-S number. You may acquire a D-U-N-S number at no cost by calling the dedicated toll-free D-U-N-S number request line at 1-866-705-5711 or you may request a number on-line at *http://www.dnb.com* . Proof of Non-Profit Status Non-profit organizations applying for funding are required to submit proof of their non-profit status. Proof of non-profit status is any one of the following: * A reference to the applicant organization's listing in the IRS's most recent list of tax-exempt organizations described in the IRS Code. * A copy of a currently valid IRS tax exemption certificate. * A statement from a State taxing body, State attorney general, or other appropriate State official certifying that the applicant organization has non-profit status and that none of the net earnings accrue to any private shareholders or individuals. * A certified copy of the organization's certificate of incorporation or similar document that clearly establishes non-profit status. * Any of the items in the subparagraphs immediately above for a State or national parent organization and a statement signed by the parent organization that the applicant organization is a local non-profit affiliate. When applying electronically we strongly suggest that you attach your proof of non-profit status with your electronic application. Private, non-profit organizations are encouraged to submit with their applications the survey located under “Grant Related Documents and Forms”, “Survey for Private, Non-Profit Grant Applicants”, titled, “Survey on Ensuring Equal Opportunity for Applicants”, at: *http://www.acf.hhs.gov/programs/ofs/forms.htm* . Disqualification Factors Applications that exceed the ceiling amount will be deemed non-responsive and will not be considered for funding under this announcement. Any application that fails to satisfy the deadline requirements referenced in *Section IV.3* will be deemed non-responsive and will not be considered for funding under this announcement. IV. Application and Submission Information 1. Address To Request Application Package Margaret Schaefer, U.S. Department of Health and Human Services, Administration on Developmental Disabilities, 370 L'Enfant Promenade, SW., Mail Stop HHH 405-D, Washington, DC 20447. Phone:
(202)690-5962. E-mail: *mschaefer@acf.hhs.gov* . 2. Content and Form of Application Submission Letter of Intent Applicants are strongly encouraged to notify Margaret Schaefer at 202-690-5962 or by e-mail at *mschaefer@acf.hhs.gov* of their intention to submit an application under this announcement. Please submit the letter of intent by the deadline date listed in *Section IV.3.* The letter of intent should include the following information: the number and title of this announcement (required); the name and address of your organization; and your contact person's name, phone number, fax number, and email address. Letter of intent information will be used to determine the number of expert reviewers needed to evaluate applications. Failure to submit a letter of intent will not impact eligibility to submit an application and will not disqualify an application from competitive review. The Application Each application package must include the original and two copies of the complete application. Each copy should be stapled securely (front and back if necessary) in the upper left-hand corner. All pages of the narrative (including charts, tables, maps, exhibits, etc.) must be sequentially numbered, beginning with page one. In order to facilitate handling, please do not use covers, binders, or tabs. Do not include extraneous materials as attachments, such as agency promotion brochures, slides, tapes, film clips, minutes of meetings, survey instruments, or articles of incorporation. Application Requirements A complete application consists of the following items in this order: Application for Federal Assistance (Standard Form
(SF)424); Budget Information—Non-Construction Programs (SF-424A); Budget Justification for Section B—Budget Categories; Proof of designation as a lead agency (See Section III); Table of Contents; Proof on Non-Profit Status, if applicable, (See Section III.3); Copy of the applicant's approved indirect cost rate agreement, if applicable; Project Summary/Abstract; Project Narrative; Any appendices/attachments (e.g., support letters); Assurances—Non-Construction Programs (SF-424B); Certification Regarding Lobbying (SF-LLL); and Certification of the Pro-Children Act of 1994 (Environmental Tobacco Smoke), signature on the application represents certification. Application Format Length: Applications, including all forms and attachments, must not exceed 50 pages. Forms and Certifications The project description should include all the information requirements described in the specific evaluation criteria outlined in this program announcement under Section V. Application Review Information. In addition to the project description, the applicant needs to complete all of the Standard Forms required as a part of the application process for awards under this announcement. Applicants seeking financial assistance under this announcement must file the appropriate Standard Forms as described in this section. All applicants must submit SF-424, Application for Federal Assistance. For non-construction programs, applicants must also submit SF-424A, Budget Information and SF-424B, Assurances. For construction programs, applicants must also submit SF-424C, Budget Information and SF-424D, Assurances. The forms may be reproduced for use in submitting applications. Applicants must sign and return the standard forms with their application. Applicants must furnish prior to award an executed copy of the SF-LLL, Certification Regarding Lobbying, when applying for an award in excess of $100,000. Applicants who have used non-Federal funds for lobbying activities in connection with receiving assistance under this announcement shall complete a disclosure form, if applicable, with their application. Applicants must sign and return the certification with their application. Applicants must also understand that they will be held accountable for the smoking prohibition included within Public Law (Pub. L.) 103-227, Title XII Environmental Tobacco Smoke (also known as the PRO-KIDS Act of 1994). A copy of the Federal Register notice that implements the smoking prohibition is included with this form. By signing and submitting the application, applicants are providing the necessary certification and are not required to return it. Applicants must make the appropriate certification of their compliance with all Federal statutes relating to nondiscrimination. By signing and submitting the application, applicants are providing the necessary certification and are not required to return it. Complete the standard forms and the associated certifications and assurances based on the instructions on the forms. The forms and certifications may be found at: *http://www.acf.hhs.gov/programs/ofs/forms.htm.* Private, non-profit organizations are encouraged to submit with their applications the survey located under “Grant Related Documents and Forms”, “Survey for Private, Non-Profit Grant Applicants”, titled, “Survey on Ensuring Equal Opportunity for Applicants”, at: *http://www.acf.hhs.gov/programs/ofs/forms.htm.* Those organizations required to provide proof of non-profit status, please refer to *Section III.3.* Please see *Section V.1* for instructions on preparing the full project description. Please reference *Section IV.3* for details about acknowledgement of received applications. Electronic Submission You may submit your application to us in either electronic or paper format. To submit an application electronically, please use the *http://www.Grants.gov* site. If you use Grants.gov, you will be able to download a copy of the application package, complete it off-line, and then upload and submit the application via the Grants.gov site. ACF will not accept grant applications via email or facsimile transmission. *Important Note:* To submit an electronic application, you must complete the organization registration process as well as obtain and register “electronic signature credentials” for the Authorized Organization Representative (AOR). It is important to start this process early, well in advance of the application deadline, since this may take more than five business days. Please note the following if you plan to submit your application electronically via Grants.gov: * Electronic submission is voluntary, but strongly encouraged. * You may access the electronic application for this program on *http://www.Grants.gov.* * When you enter the Grants.gov site, you will find information about submitting an application electronically through the site, as well as the hours of operation. We strongly recommend that you do not wait until the application deadline date to begin the application process through Grants.gov. We encourage applicants who submit electronically to submit well before the closing date and time so that if difficulties are encountered an applicant can still send in a hard copy overnight. * To use Grants.gov, you, as the applicant, must have a D-U-N-S number and register in the Central Contractor Registry (CCR). You should allow a minimum of five days to complete the CCR registration. REMINDER: CCR registration must be updated annually. * The electronic application is submitted by the AOR. To submit electronically, the AOR must obtain and register electronic signature credentials approved by the organization's E-Business Point of Contact who maintains the organization's CCR registration. Checklists are maintained on *http://www.grants.gov/GetStarted.* * You may submit all documents electronically, including all information typically included on the SF-424 and all necessary assurances and certifications. * Your application must comply with any page limitation requirements described in this program announcement. * After you electronically submit your application, you will receive an automatic acknowledgement from Grants.gov that contains a Grants.gov tracking number. ACF will retrieve your application from Grants.gov. * ACF may request that you provide original signatures on forms at a later date. * You may access the electronic application for this program on *http://www.Grants.gov.* You may search for the downloadable application package by the Catalog of Federal Domestic Assistance
(CFDA)number. * You will not receive additional point value because you submit a grant application in electronic format, nor will we penalize you if you submit an application in hard copy. Hard Copy Submission Applicants that are submitting their application in paper format should submit one original and two copies of the complete application. The original and each of the two copies must include all required forms, certifications, assurances, and appendices, be signed by an authorized representative, have original signatures, and be unbound. Non-Federal Reviewers Since ACF will be using non-Federal reviewers in the review process, applicants have the option of omitting from the application copies (not the original) specific salary rates or amounts for individuals specified in the application budget as well as Social Security Numbers, if otherwise required for individuals. The copies may include summary salary information. If applicants are submitting their application electronically, ACF will omit the same specific salary rate information from copies made for use during the review and selection process. 3. Submission Dates and Times *Due Date for Letter of Intent:* March 27, 2006. *Due Date for Applications:* April 24, 2006. Explanation of Due Dates The closing time and date for receipt of applications is referenced above. Applications received after 4:30 p.m., eastern time, on the closing date will be classified as late and will not be considered in the current competition. Applicants are responsible for ensuring that applications are mailed or submitted electronically well in advance of the application due date. Applications hand carried by applicants, applicant couriers, other representatives of the applicant, or by overnight/express mail couriers shall be considered as meeting an announced deadline if they are received on or before the deadline date, between the hours of 8 a.m. and 4:30 p.m., eastern time, at the address referenced in *Section IV.6.,* between Monday and Friday (excluding Federal holidays). ACF cannot accommodate transmission of applications by facsimile or e-mail. Late Applications Applications that do not meet the requirements above are considered late applications. ACF shall notify each late applicant that its application will not be considered in the current competition. Any application received after 4:30 p.m., eastern time, on the deadline date will not be considered for competition. Applicants using express/overnight mail services should allow two working days prior to the deadline date for receipt of applications. Applicants are cautioned that express/overnight mail services do not always deliver as agreed. Extension of Deadlines ACF may extend application deadlines when circumstances such as acts of God (floods, hurricanes, etc.) occur; when there are widespread disruptions of mail service; or in other rare cases. A determination to extend or waive deadline requirements rests with the Chief Grants Management Officer. Receipt acknowledgement for application packages will not be provided to applicants who submit their package via mail, courier services, or by hand delivery. Applicants will receive an electronic acknowledgement for applications that are submitted via *http://www.Grants.gov.* Checklist What to submit Required content Required form or format When to submit Project Abstract See Sections IV.2 and V Found in Sections IV.2 and V By application due date. Project Description See Sections IV.2 and V Found in Sections IV.2 and V By application due date. Budget Narrative/Justification See Sections IV.2 and V Found in Sections IV.2 and V By application due date. SF-424 See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By application due date. SF-LLL Certification Regarding Lobbying See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By date of award. Certification Regarding Environmental Tobacco Smoke See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By date of award. Assurances See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By date of award. Letter of Intent See Section IV.2 Found in Section IV.2 March 27, 2006. Table of Contents See Section IV.2 Found in Section IV.2 By application due date. SF-424A See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By application due date. Support Letters See Section V Found in Section V By application due date. SF-424B See Section IV.2 See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By application due date. Proof of Non-Profit Status See Section III.3 Found in Section III.3 By date of award. Proof of Designation as Lead Agency (if appropriate) See Sections III and IV.2 Found in Sections III and IV.2 By application due date. Copy of Approved Indirect Cost Rate Agreement See Section V Found in Section V By date of award. Additional Forms Private, non-profit organizations are encouraged to submit with their applications the survey located under “Grant Related Documents and Forms”, “Survey for Private, Non-Profit Grant Applicants”, titled, “Survey on Ensuring Equal Opportunity for Applicants”, at: *http://www.acf.hhs.gov/programs/ofs/forms.htm.* What to submit Required content Required form or format When to submit Survey for Private, Non-Profit Grant Applicants See form See *http://www.acf.hhs.gov/programs/ofs/forms.htm* By application due date. 4. Intergovernmental Review State Single Point of Contact
(SPOC)This program is covered under Executive Order
(EO)12372, “Intergovernmental Review of Federal Programs,” and 45 CFR part 100, “Intergovernmental Review of Department of Health and Human Services Programs and Activities.” Under the Order, States may design their own processes for reviewing and commenting on proposed Federal assistance under covered programs. As of August 1, 2005, the following jurisdictions have elected to participate in the EO process: Arkansas, California, Delaware, District of Columbia, Florida, Georgia, Illinois, Iowa, Kentucky, Maine, Maryland, Michigan, Mississippi, Missouri, Nevada, New Hampshire, New York, North Dakota, Rhode Island, South Carolina, Texas, Utah, West Virginia, Wisconsin, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and U.S. Virgin Islands. As these jurisdictions have elected to participate in the Executive Order process, they have established SPOCs. Applicants from participating jurisdictions should contact their SPOC, as soon as possible, to alert them of prospective applications and receive instructions. Applicants must submit all required materials, if any, to the SPOC and indicate the date of this submittal (or the date of contact if no submittal is required) on the Standard Form 424, item 16a. Under 45 CFR 100.8(a)(2), a SPOC has 60 days from the application deadline to comment on proposed new or competing continuation awards. SPOCs are encouraged to eliminate the submission of routine endorsements as official recommendations. Additionally, SPOCs are requested to clearly differentiate between mere advisory comments and those official State process recommendations, which may trigger the “accommodate or explain” rule. When comments are submitted directly to ACF, they should be addressed to the U.S. Department of Health and Human Services, Administration for Children and Families, Office of Grants Management, Division of Discretionary Grants, 370 L'Enfant Promenade SW., 4th floor, Washington, DC 20447. Although the remaining jurisdictions have chosen not to participate in the process, entities that meet the eligibility requirements of the program are still eligible to apply for a grant even if a State, Territory, Commonwealth, etc. does not have a SPOC. Therefore, applicants from these jurisdictions, or for projects administered by Federally recognized Indian Tribes, need take no action in regard to EO 12372. The official list, including addresses, of the jurisdictions that have elected to participate in EO 12372 can be found on the following URL: *http://www.whitehouse.gov/omb/grants/spoc.html.* 5. Funding Restrictions Grant awards will not allow reimbursement of pre-award costs. Construction is not an allowable activity or expenditure under this program. 6. Other Submission Requirements Please see *Sections IV.2* and *IV.3* for deadline information and other application requirements. Submit applications to one of the following addresses: Submission by Mail Tim Chappelle, U.S. Department of Health and Human Services, Administration for Children and Families, Office of Grants Management, 370 L'Enfant Promenade, SW., Washington, DC 20447. Hand Delivery Tim Chappelle, U.S. Department of Health and Human Services, Administration for Children and Families, Office of Grants Management, 370 L'Enfant Promenade, SW., Washington, DC 20024. Electronic Submission Please see *Section IV.2* for guidelines and requirements when submitting applications electronically via *http://www.Grants.gov.* V. Application Review Information The Paperwork Reduction Act of 1995 (Pub. L. 104-13) Public reporting burden for this collection of information is estimated to average 50 hours per response, including the time for reviewing instructions, gathering and maintaining the data needed and reviewing the collection information. The project description is approved under OMB control number 0970-0139 which expires April 30, 2007. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. 1. Criteria Part I The Project Description Overview Purpose The project description provides the majority of information by which an application is evaluated and ranked in competition with other applications for available assistance. The project description should be concise and complete. It should address the activity for which Federal funds are being requested. Supporting documents should be included where they can present information clearly and succinctly. In preparing the project description, information that is responsive to each of the requested evaluation criteria must be provided. Awarding offices use this and other information in making their funding recommendations. It is important, therefore, that this information be included in the application in a manner that is clear and complete. General Expectations and Instructions ACF is particularly interested in specific project descriptions that focus on outcomes and convey strategies for achieving intended performance. Project descriptions are evaluated on the basis of substance and measurable outcomes, not length. Extensive exhibits are not required. Cross-referencing should be used rather than repetition. Supporting information concerning activities that will not be directly funded by the grant or information that does not directly pertain to an integral part of the grant funded activity should be placed in an appendix. Pages should be numbered and a table of contents should be included for easy reference. Part II General Instructions for Preparing a Full Project Description Introduction Applicants that are required to submit a full project description shall prepare the project description statement in accordance with the following instructions while being aware of the specified evaluation criteria. The text options give a broad overview of what the project description should include while the evaluation criteria identify the measures that will be used to evaluate applications. Project Summary/Abstract Provide a summary of the project description (one page or less) with reference to the funding request. Objectives and Need for Assistance Clearly identify the physical, economic, social, financial, institutional, and/or other problem(s) requiring a solution. The need for assistance must be demonstrated and the principal and subordinate objectives of the project must be clearly stated; supporting documentation, such as letters of support and testimonials from concerned interests other than the applicant, may be included. Any relevant data based on planning studies should be included or referred to in the endnotes/footnotes. Incorporate demographic data and participant/beneficiary information, as needed. In developing the project description, the applicant may volunteer or be requested to provide information on the total range of projects currently being conducted and supported (or to be initiated), some of which may be outside the scope of the program announcement. Results or Benefits Expected Identify the results and benefits to be derived. For example, describe how the activities that your organization undertakes will promote full participation in the electoral process, including registering to vote, casting a vote, and accessing polling places, for individuals with the full range of disabilities. Approach Outline a plan of action that describes the scope and detail of how the proposed work will be accomplished. Account for all functions or activities identified in the application. Cite factors that might accelerate or decelerate the work and state your reason for taking the proposed approach rather than others. Describe any unusual features of the project such as design or technological innovations, reductions in cost or time, or extraordinary social and community involvement. Provide quantitative monthly or quarterly projections of the accomplishments to be achieved for each function or activity in such terms as the number of people to be served and the number of activities accomplished. When accomplishments cannot be quantified by activity or function, list them in chronological order to show the schedule of accomplishments and their target dates. If any data is to be collected, maintained, and/or disseminated, clearance may be required from the OMB. This clearance pertains to any “collection of information that is conducted or sponsored by ACF.” Provide a list of organizations, cooperating entities, consultants, or other key individuals who will work on the project along with a short description of the nature of their effort or contribution. Evaluation Provide a narrative addressing how the conduct of the project and the results of the project will be evaluated. In addressing the evaluation of results, state how you will determine the extent to which the project has achieved its stated objectives and the extent to which the accomplishment of objectives can be attributed to the project. Discuss the criteria to be used to evaluate results, and explain the methodology that will be used to determine if the needs identified and discussed are being met and if the project results and benefits are being achieved. With respect to the conduct of the project, define the procedures to be employed to determine whether the project is being conducted in a manner consistent with the work plan presented and discuss the impact of the project's various activities that address the project's effectiveness. Organizational Profiles Provide information on the applicant organization(s) and cooperating partners, such as: Organizational charts; financial statements; audit reports or statements from Certified Public Accountants/Licensed Public Accountants; Employer Identification Number(s); contact persons and telephone numbers; names of bond carriers; child care licenses and other documentation of professional accreditation; information on compliance with Federal/State/local government standards; documentation of experience in the program area; and, other pertinent information. If the applicant is a non-profit organization, it should submit proof of its non-profit status in its application. The non-profit agency can accomplish this by providing any one of the following:
(a)A reference to the applicant organization's listing in the IRS's most recent list of tax-exempt organizations described in the IRS Code;
(b)a copy of a currently valid IRS tax exemption certificate;
(c)a statement from a State taxing body, State attorney general, or other appropriate State official certifying that the applicant organization has a non-profit status and that none of the net earnings accrues to any private shareholders or individuals;
(d)a certified copy of the organization's certificate of incorporation or similar document that clearly establishes non-profit status;
(e)any of the items immediately above for a State or national parent organization and a statement signed by the parent organization that the applicant organization is a local non-profit affiliate. Budget and Budget Justification Provide a budget with line item detail and detailed calculations for each budget object class identified on the Budget Information Form (SF-424A or SF-424C). Detailed calculations must include estimation methods, quantities, unit costs, and other similar quantitative detail sufficient for the calculation to be duplicated. If matching is a requirement, include a breakout by the funding sources identified in Block 15 of the SF-424. Provide a narrative budget justification that describes how the categorical costs are derived. Discuss the necessity, reasonableness, and allocation of the proposed costs. General Use the following guidelines for preparing the budget and budget justification. Both Federal and non-Federal resources (when required) shall be detailed and justified in the budget and budget narrative justification. “Federal resources” refers only to the ACF grant funds for which you are applying. “Non Federal resources” are all other non-ACF Federal and non-Federal resources. It is suggested that budget amounts and computations be presented in a columnar format: First column, object class categories; second column, Federal budget; next column(s), non-Federal budget(s); and last column, total budget. The budget justification should be in a narrative form. Personnel *Description:* Costs of employee salaries and wages. *Justification:* Identify the project director or principal investigator, if known at the time of application. For each staff person, provide: the title; time commitment to the project in months; time commitment to the project as a percentage or full-time equivalent; annual salary; grant salary; wage rates; etc. Do not include the costs of consultants, personnel costs of delegate agencies, or of specific project(s) and/or businesses to be financed by the applicant. Fringe Benefits *Description:* Costs of employee fringe benefits unless treated as part of an approved indirect cost rate. *Justification:* Provide a breakdown of the amounts and percentages that comprise fringe benefit costs such as health insurance, FICA, retirement insurance, taxes, etc. Travel *Description:* Costs of project-related travel by employees of the applicant organization. (This item does not include costs of consultant travel). *Justification:* For each trip show: the total number of traveler(s); travel destination; duration of trip; per diem; mileage allowances, if privately owned vehicles will be used; and other transportation costs and subsistence allowances. Travel costs for key staff to attend ACF-sponsored workshops should be detailed in the budget. Equipment *Description:* “Equipment” means an article of nonexpendable, tangible personal property having a useful life of more than one year and an acquisition cost that equals or exceeds the lesser of:
(a)The capitalization level established by the organization for the financial statement purposes, or
(b)$5,000. (Note: Acquisition cost means the net invoice unit price of an item of equipment, including the cost of any modifications, attachments, accessories, or auxiliary apparatus necessary to make it usable for the purpose for which it is acquired. Ancillary charges, such as taxes, duty, protective in-transit insurance, freight, and installation, shall be included in or excluded from acquisition cost in accordance with the organization's regular written accounting practices.) *Justification:* For each type of equipment requested provide: a description of the equipment; the cost per unit; the number of units; the total cost; and a plan for use on the project; as well as use and/or disposal of the equipment after the project ends. An applicant organization that uses its own definition for equipment should provide a copy of its policy, or section of its policy, that includes the equipment definition. Supplies *Description:* Costs of all tangible personal property other than that included under the Equipment category. *Justification:* Specify general categories of supplies and their costs. Show computations and provide other information that supports the amount requested. Contractual *Description:* Costs of all contracts for services and goods except for those that belong under other categories such as equipment, supplies, construction, etc. Include third party evaluation contracts, if applicable, and contracts with secondary recipient organizations, including delegate agencies and specific project(s) and/or businesses to be financed by the applicant. *Justification:* Demonstrate that all procurement transactions will be conducted in a manner to provide, to the maximum extent practical, open and free competition. Recipients and subrecipients, other than States that are required to use 45 CFR part 92 procedures, must justify any anticipated procurement action that is expected to be awarded without competition and exceeds the simplified acquisition threshold fixed at 41 U.S.C. 403(11), currently set at $100,000. Recipients might be required to make available to ACF pre-award review and procurement documents, such as requests for proposals or invitations for bids, independent cost estimates, etc. Note: Whenever the applicant intends to delegate part of the project to another agency, the applicant must provide a detailed budget and budget narrative for each delegate agency, by agency title, along with the required supporting information referred to in these instructions. Other Enter the total of all other costs. Such costs, where applicable and appropriate, may include but are not limited to: Insurance; food; medical and dental costs (noncontractual); professional services costs; space and equipment rentals; printing and publication; computer use; training costs, such as tuition and stipends; staff development costs; and administrative costs. *Justification:* Provide computations, a narrative description and a justification for each cost under this category. Indirect Charges *Description:* Total amount of indirect costs. This category should be used only when the applicant currently has an indirect cost rate approved by the Department of Health and Human Services
(HHS)or another cognizant Federal agency. *Justification:* An applicant that will charge indirect costs to the grant must enclose a copy of the current rate agreement. If the applicant organization is in the process of initially developing or renegotiating a rate, upon notification that an award will be made, it should immediately develop a tentative indirect cost rate proposal based on its most recently completed fiscal year, in accordance with the cognizant agency's guidelines for establishing indirect cost rates, and submit it to the cognizant agency. Applicants awaiting approval of their indirect cost proposals may also request indirect costs. When an indirect cost rate is requested, those costs included in the indirect cost pool should not be charged as direct costs to the grant. Also, if the applicant is requesting a rate that is less than what is allowed under the program, the authorized representative of the applicant organization must submit a signed acknowledgement that the applicant is accepting a lower rate than allowed. Program Income *Description:* The estimated amount of income, if any, expected to be generated from this project. *Justification:* Describe the nature, source and anticipated use of program income in the budget or refer to the pages in the application that contain this information. Evaluation Criteria The following evaluation criteria appear in weighted descending order. The corresponding score values indicate the relative importance that ACF places on each evaluation criterion; however, applicants need not develop their applications precisely according to the order presented. Application components may be organized such that a reviewer will be able to follow a seamless and logical flow of information ( *i.e.* , from a broad overview of the project to more detailed information about how it will be conducted). In considering how applicants will carry out the responsibilities addressed under this announcement, competing applications for financial assistance will be reviewed and evaluated against the following criteria: Approach—35 points Applicants will be evaluated based on the extent to which they present a plan that
(1)clearly reflects an understanding of the characteristics, needs and services currently available to the targeted population;
(2)provides appropriate services that directly address the needs of the targeted population;
(3)is evidence-based and grounded in theory and practice;
(4)is appropriate and feasible; and
(5)can be reliably evaluated. * Applications will be evaluated based on the extent to which they outline a plan of action pertaining to the scope and detail on how the proposed work will be accomplished for each project and include a definition of the goals and specific measurable objectives for the project. (8 points). * Applications will be evaluated based on the extent to which they identify the kinds of data to be collected and maintained, and discuss the criteria to be used to evaluate the results and success of the project. For example, the applicant may provide a description of how the proposed project will be evaluated to determine the extent to which it has achieved its stated goals and objectives; the applicant may also provide a description of methods of evaluation that include the use of performance measures that are clearly related to the intended outcome of the project. (8 points). * Applications will be evaluated based on the extent to which they describe any unusual features of the project, such as design or technological innovation, reductions in cost or time, or extraordinary social and community involvement. (5 points). * Applications will be evaluated based on the extent to which they provide for each project, when possible, a quantitative description of the accomplishments to be achieved and, when quantification is not possible, a list of activities, in chronological order, to show the schedule of accomplishments and their target dates. (4 points). * Applications will be evaluated based on the extent to which they describe the products to be developed during the implementation of the proposed project, such as questionnaires, interview guides, data collection instruments, software, internet applications, reports, article outcomes, evaluation results, and a dissemination plan for conveying the information. (4 points). * Applications will be evaluated based on the extent to which they cite factors that might accelerate or decelerate the work and provide reasons for taking this approach as opposed to others. (3 points). * Applications will be evaluated based on the extent to which they list each organization, operator, consultant, or other key individual who will work on the project along with a short description of their contributions. (3 points). Objectives and Need for Assistance—25 points Applications will be evaluated based on the extent to which the applicant describes the context of this project, including the geographic location, environment, magnitude and severity of the problem(s) to be solved, and the needs to be addressed. * Applications will be evaluated based on the extent to which they demonstrate the need for assistance and describe the principal and subordinate objectives for the project. (10 points). * Applications will be evaluated based on the extent to which they specifically mention any relevant physical, economic, social, financial, institutional, or other problems requiring a solution. (5 points). * Applications will be evaluated based on the extent to which they provide supporting documentation or other testimonies from concerned interests other than the applicant. (5 points). * Applications will be evaluated based on the extent to which they provide relevant data based on planning studies. (4 points). * Applications will be evaluated based on the extent to which they provide relevant maps and other graphic aids. (1 point). Results Or Benefits Expected—20 points Applications will be evaluated based on the extent to which they identify the results and benefits to be derived and the anticipated contribution to policy, practice, theory, and research. * Applications will be evaluated based on the extent to which they clearly describe the project benefits and results as they relate to the objectives of the project. (10 points). * Applications will be evaluated based on the extent to which they provide information regarding how the project will build on current theory, research, evaluation and best practices to contribute to increased knowledge and understanding of the problems, issues, or effective strategies and practices in T/TA. (10 points). Organizational Profiles—15 points Applications will be evaluated based on the extent to which they identify how the applicant organization (or the unit within the organization that will have responsibility for the project) is structured, the types and quantity of services, and the research and management capabilities it possesses. Applications will be evaluated based on the extent to which the applicant demonstrates a capacity to implement the proposed project, including
(1)experience with similar projects;
(2)experience with the target population;
(3)qualifications and experience of the project leadership;
(4)commitment to developing and sustaining work among key stakeholders;
(5)experience and commitment of any proposed consultants and subcontractors; and
(6)appropriateness of the organizational structure, including its management information system, to carry out the project. * Applications will be evaluated based on the extent to which they identify the background of the project director/principal investigator and key project staff (such as the inclusion of name, address, training, educational background, and other qualifying experience) and the extent to which they demonstrate that the experience of the organization is such that the applicant may effectively and efficiently administer this project, for example, the applicant may provide brief resumes of key project staff. (4 points). * Applications will be evaluated based on the extent to which they provide a brief background description of how the applicant organization is organized, the types and quantity of services it provides, and the research and management capabilities it possesses. (4 points). * Applications will be evaluated based on the extent to which they describe the competence of the project team and its demonstrated ability to deliver a final product that is readily comprehensible and usable. (4 points). * Applications will be evaluated based on the extent to which they demonstrate the direct relationship of the project to the applicant organization such as an organizational chart that illustrates the relationship of the project to the current organization. (3 points). Budget and Budget Justification—5 points Applications will be evaluated based on the extent to which the applicant presents a budget with reasonable project costs, appropriately allocated across component areas and sufficient to accomplish the objectives, such as the inclusion of a justification for and documentation of the dollar amount requested. Applications will be evaluated based upon the extent to which they include a narrative budget justification that describes how the categorical costs are derived and a discussion of the reasonableness and appropriateness of the proposed costs. Line-item allocations and justifications are required for Federal funds. * Applications will be evaluated based on the extent to which they discuss and justify the costs of the proposed project as being reasonable and programmatically justified in view of the activities to be conducted and the anticipated results and benefits. (3 points). * Applications will be evaluated based on the extent to which they describe the fiscal controls and accounting procedures that will be used to ensure prudent use, proper disbursement, and accurate accounting of funds received under this program announcement. (2 points). Note: Applicants have the option of omitting the Social Security Numbers and specific salary rates of the proposed project personnel from the two copies submitted with the original applications to ACF. For purposes of the outside review process, applicants may elect to summarize salary information on the copies of their application. All necessary salary information must, however, appear on the signed original application for ACF. 2. Review and Selection Process No grant award will be made under this announcement on the basis of an incomplete application. Each application submitted under this program announcement will undergo a pre-review to determine that
(1)the application was received by the closing date (See *Section IV.3* ) and
(2)that the amount requested does not exceed the stated ceiling (See Section II). It is necessary that applicants state specifically for which funding announcement they are applying. Applications will be evaluated and rated by an independent review panel on the basis of specific evaluation criteria. The results of these reviews will assist the ADD Commissioner and program staff in considering competing applications. Reviewers' scores will weigh heavily in funding decisions but will not be the only factors considered. Applications generally will be considered in order of the average scores assigned by reviewers. The evaluation criteria were designed to assess the quality of a proposed project and to determine the likelihood of its success. The evaluation criteria are closely related and are considered as a whole in judging the overall quality of an application. Points are awarded only to applications that are responsive to the evaluation criteria within the context of this program announcement. Non-Federal reviewers will be used for the review process. Please reference Section IV.2 for information on non-Federal reviewers in the review process. Approved but Unfunded Applications Applications that are approved but unfunded may be held over for funding in the next funding cycle, pending the availability of funds, for a period not to exceed one year. VI. Award Administration Information 1. Award Notices The successful applicants will be notified through the issuance of a Financial Assistance Award document which sets forth the amount of funds granted, the terms and conditions of the grant, the effective date of the grant, the budget period for which initial support will be given, the non-Federal share to be provided (if applicable), and the total project period for which support is contemplated. The Financial Assistance Award will be signed by the Grants Officer and transmitted via postal mail. Organizations whose applications will not be funded will be notified in writing. 2. Administrative and National Policy Requirements Grantees are subject to the requirements in 45 CFR part 74 (non-governmental) or 45 CFR part 92 (governmental). Direct Federal grants, sub-award funds, or contracts under this ACF program shall not be used to support inherently religious activities such as religious instruction, worship, or proselytization. Therefore, organizations must take steps to separate, in time or location, their inherently religious activities from the services funded under this program. Regulations pertaining to the Equal Treatment for Faith-Based Organizations, which includes the prohibition against Federal funding of inherently religious activities, can be found at the HHS Web site at *http://www.os.dhhs.gov/fbci/waisgate21.pdf.* Faith-based and community organizations may reference the “Guidance to Faith-Based and Community Organizations on Partnering with the Federal Government” at *http://www.whitehouse.gov/government/fbci/guidance/index.html.* 3. Reporting Requirements Grantees will be required to submit program progress and financial reports (SF-269 found at *http://www.acf.hhs.gov/programs/ofs/forms.htm* ) throughout the project period. Program progress and financial reports are due 30 days after the reporting period. Final programmatic and financial reports are due 90 days after the close of the project period. Program Progress Reports: Quarterly. Financial Reports: Quarterly. VII. Agency Contacts Program Office Contact Margaret Schaefer, Administration for Children and Families, Administration on Developmental Disabilities, 370 L'Enfant Promenade, SW., Mail Stop HHH 405-D, Washington, DC 20447. Phone: 202-690-5962. Fax: 202-205-8037. E-mail: *mschaefer@acf.hhs.gov.* Grants Management Office Contact Tim Chappelle, Administration for Children and Families, Office of Grants Management, 370 L'Enfant Promenade, SW., Washington, DC 20447. Phone: 202-401-4855. E-mail: *tichappelle@acf.hhs.gov.* VIII. Other Information Additional information about this program and its purpose can be located on the following Web sites: *http://www.acf.hhs.gov/programs/add* and *http://www.nass.org.* Dated: February 13, 2006. Patricia A. Morrissey, Commissioner, Administration on Developmental Disabilities. [FR Doc. E6-2515 Filed 2-22-06; 8:45 am] BILLING CODE 4184-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. *Name of Committee* : Cardiovascular and Renal Drugs Advisory Committee. *General Function of the Committee* : To provide advice and recommendations to the agency on FDA's regulatory issues. *Date and Time* : The meeting will be held on April 25 and 26, 2006, from 8 a.m. to 5 p.m. *Location* : Hilton Washington DC North/Gaithersburg, The Ballrooms, 620 Perry Pkwy., Gaithersburg, MD, 301-977-8900. *Contact Person* : Cathy Groupe, Center for Drug Evaluation and Research (HFD- 21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857, 301-827-7001, e-mail: *Cathy.Groupe@fda.hhs.gov* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512533. Please call the Information Line for up-to-date information on this meeting. *Agenda* : On April 25, 2006, the committee will meet between 8 a.m. to 5 p.m., to discuss new drug application
(NDA)21-359 CELLEGESIC (nitroglycerin [NTG] ointment), 0.4% intra-anal, Cellegy Pharmaceuticals, Inc., for the proposed indication of relief of pain associated with anal fissures. On April 26, 2006, the committee will meet between 8 a.m. to 12 noon, to discuss the agency's draft recommendations for relabeling of antihypertensive drugs for outcome claims, as a followup to the committee's meeting on June 15, 2005, where the committee discussed class labeling of antihypertensive drugs based on the proximity of their data to outcome trials. Following this, from approximately 1 p.m. to 5 p.m., the committee will discuss the “Placebo in Hypertension Adverse Reaction Meta-Analysis” Study, a meta-analysis of more than 80,000 patients in placebo-controlled trials of antihypertensive medications, which evaluated the risk of irreversible harm in conducting placebo-controlled trials in patients with hypertension. The background material will become available no later than the day before the meeting and will be posted on FDA's Web site at *http://www.fda.gov/orhms/dockets/ac/acmenu.htm* under the heading “Cardiovascular and Renal Drugs Advisory Committee.” (Click on the year 2006 and scroll down to the above named committee). *Procedure* : Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by April 14, 2006. On April 25, 2006, oral presentations from the public will be scheduled between approximately 8:15 a.m. to 8:45 a.m. On April 26, 2006, oral presentations from the public will be scheduled between approximately 8:15 a.m. to 8:45 a.m. and 1 p.m. to 1:30 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before April 14, 2006, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants and an indication of the approximate time requested to make their presentation. Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact John Lauttman at least 7 days in advance of the meeting at 301-827-7001. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: February 15, 2006. Jason Brodsky, Acting Associate Commissioner for External Relations. [FR Doc. E6-2542 Filed 2-22-06; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Peripheral and Central Nervous System Drugs Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration
(FDA)is announcing an amendment to the notice of meeting of the Peripheral and Central Nervous System Drugs Advisory Committee. This meeting was announced in the **Federal Register** of January 27, 2006 (71 FR 4593). The amendment is being made to reflect a change in *Date and Time* and *Procedure* portions of the document. An additional day is being added to this meeting and the length of time allotted for the open public hearing portion is being extended. There are no other changes. FOR FURTHER INFORMATION CONTACT: Sohail Mosaddegh, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *sohail.mosaddegh@fda.hhs.gov* , or the FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), code 3014512543. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the **Federal Register** of January 27, 2006, FDA announced that a meeting of the Peripheral and Central Nervous System Drugs Advisory Committee would be held on March 7, 2006, from 8 a.m. to 5 p.m., and the open public hearing portion scheduled between approximately 1 p.m. and 2 p.m. On page 4593, in the third column, the *Date and Time* portion of the document is amended to read as follows: *Date and Time* : The meeting will be held on March 7 and 8, 2006, from 8 a.m. to 5 p.m. On page 4594, in the first column, in the *Procedure* portion of the document, the third sentence is amended to read as follows: *Procedure* : Oral presentations from the public will be scheduled between approximately 1 p.m. and 5 p.m. on March 7, 2006. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees. Dated: February 15, 2006. Jason Brodsky, Acting Associate Commissioner for External Relations. [FR Doc. E6-2541 Filed 2-22-06; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Proposed Collection; Comment Request; The Sister Study: A Prospective Study of the Genetic and Environmental Risk Factors for Breast Cancer SUMMARY: In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute of Environmental Health Sciences (NIEHS), the National Institutes of Health
(NIH)will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget
(OMB)for review and approval. *Proposed Collection: Title:* The Sister Study: A Prospective Study of the Genetic and Environmental Risk Factors for Breast Cancer. *Type of Information Collection Request:* Revision of OMB No. 0925-0522 and expiration date 31 July 2006. *Need and Use of Information Collection:* The purpose of the Sister Study is to study genetic and environmental risk factors for the development of breast cancer in a cohort of sisters of women who have had breast cancer. In the United States, there were approximately 210,000 new cases in 2003, accounting for 30% of all new cancer cases among women. The etiology of breast cancer is complex, with both genetic and environmental factors likely playing a role. Environmental risk factors, however, have been difficult to identify. By focusing on genetically susceptible subgroups, more precise estimates of the contribution of environmental and other non-genetic factors to disease risk may be possible. Sisters of women with breast cancer are one group at increased risk for breast cancer; we would expect about 2 times as many breast cancers to accrue in a cohort of sisters as would accrue in a cohort identified through random sampling or other means. In addition, a cohort of sisters will be enriched with regard to the prevalence of relevant genes and/or exposures, further enhancing the ability to detect gene-environment interactions. Sisters of women with breast cancer will also be at increased risk for ovarian cancer and possibly for other hormonally-mediated diseases. We are enrolling a cohort of 50,000 women who have not had breast cancer. Initial recruitment of the first 2,000 women took place from August 2003-September 2004 before beginning nationwide recruitment in October 2004. The data collected in the initial phase allowed us to evaluate subject recruitment and data collection procedures, and helped us better target our recruitment efforts. We estimate that a cohort of 50,000 sisters aged 35-74 years would provide about 1,500 breast cancer cases over five years (approximately 300 new cases per year once the cohort is fully enrolled). *Frequency of Response:* At enrollment, one initial 15-minute screening (either on the telephone OR on the internet), 2 one-hour telephone interviews, 3 mailed self-administered questionnaires (90 minutes total), and some biological and household specimens collected. Women are advised that they will be contacted every year to update contact information and health status and asked to complete shorter (45-60 minutes, total) follow-up interviews or questionnaires every two years. Women diagnosed with breast cancer or other health outcomes of interest will be asked to provide additional information about their diagnosis (20 minutes per response) and their doctors will be contacted to provide documentation regarding diagnosis and treatments (15 minutes per response). *Affected Public:* Individuals or households; doctors' offices. *Type of Respondents:* Unaffected sisters of women diagnosed with breast cancer, aged 35-74, from all socioeconomic backgrounds and ethnicities. The annual reporting burden is as follows: *Estimated Number of Respondents:* 67,500 (~12,500 enrolled per year over ~4 years, plus ~14,000 persons ultimately determined ineligibles or refusals at initial screening, and 3,500 persons who partially complete enrollment before terminating). *Estimated Number of Responses per Respondent:* See table below. *Average Burden Hours per Response:* 6.0; and *Estimated Total Burden Hours Requested:* 176,553 (over 3 years). The average annual burden hours requested is 58,851. The annualized cost to respondents is estimated at $135 (assuming $20 hourly wage × 6 hours + $15 babysitting estimate). There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Activity (3-yrs) Estimated number of respondents Estimated responses per respondent Average burden hours per response Estimated total burden hours requested Eligibility Screening 22,750 1 0.25 5,688 Enrollment Interviews 22,750 1 2 45,500 Enrollment SAQs 22,750 1 1.5 34,125 Enrollment Specimen Collection * 22,750 1 1 22,750 1st Annual Update 50,000 1 0.17 8,500 1st Bienniel Follow-Up Questionnaire 50,000 1 1 50,000 2nd Annual Update 25,001 1 0.17 4,250 Ineligible ** 14,000 1 0.25 3,500 Dropout ** 3,500 1 2.25 7,875 Incident BC Case Follow-Up 1,800 1 0.33 594 Incident Other Case Follow-Up 300 1 0.33 99 Incident Case/Physician Contact 2,100 1 0.25 525 Total 183,406 * Includes waiting time, and scheduling appointment for blood draw. ** Expect 17% ineligible at screening plus 7% dropout during enrollment activities. *Request for Comments:* Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points:
(1)Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility;
(2)The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
(3)Ways to enhance the quality, utility, and clarity of the information to be collected; and
(4)Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. FOR FURTHER INFORMATION contact: To request more information on the project or to obtain a copy of the data collection plans and instruments, contact: Dr. Dale P. Sandler, Chief, Epidemiology Branch, NIEHS, Rall Building A3-05, PO Box 12233, Research Triangle Park, NC 27709 or call non-toll-free number
(919)541-4668 or E-mail your request, including your address to: *sandler@niehs.nih.gov.* *Comments Due Date:* Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Dated: February 13, 2006. Richard Freed, NIEHS, Associate Director for Management. [FR Doc. 06-1690 Filed 2-22-06; 8:45 am]
Connectionstraces to 7
13 references not yet in our index
  • 46 CFR 515
  • Pub. L. 92-463
  • 45 CFR 46
  • 44 USC 3501-3520
  • 5 CFR 1320.3(c)
  • Pub. L. 107-252
  • 45 CFR 100
  • 45 CFR 100.8(a)(2)
  • Pub. L. 104-13
  • 45 CFR 92
  • 41 USC 403(11)
  • 45 CFR 74
  • 21 CFR 14
Citation graph
cites case law
Notices
Notice
U.S.C.§ 1817
C.F.R.§ 225.41
U.S.C.§ 217a
U.S.C.§ 9601
U.S.C.§ 3502
U.S.C.§ 3506
U.S.C.§ 15461
Cite46 CFR 515
Pub. L.Pub. L. 92-463
Cite45 CFR 46
Cite44 USC 3501-3520
Cite5 CFR 1320.3(c)
Cites 20 · showing 12Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.